financetom
Business
financetom
/
Business
/
Exclusive-Volkswagen India unit faces $1.4 billion tax evasion notice
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exclusive-Volkswagen India unit faces $1.4 billion tax evasion notice
Nov 29, 2024 3:16 AM

By Aditi Shah, Aditya Kalra and Nikunj Ohri

NEW DELHI (Reuters) - India has issued a notice to German automaker Volkswagen for allegedly evading $1.4 billion in taxes by "wilfully" paying lesser import tax on components for its Audi, VW and Skoda cars, a document shows, in what is one of the biggest such demands.

A notice dated Sept. 30 says Volkswagen used to import "almost the entire" car in unassembled condition - which attracts a 30-35% import tax in India under rules for CKD, or completely knocked down units, but evaded levies by "mis-declaring and mis-classifying" those imports as "individual parts", paying just a 5-15% duty.

Such imports were made by Volkswagen's India unit, Skoda Auto Volkswagen India, for its models including the Skoda Superb and Kodiaq, luxury cars like Audi A4 and Q5, and VW's Tiguan SUV. Different shipment consignments were used to evade detection and "willfully evade payment" of higher taxes, the Indian investigation found.

"This logistical arrangement is an artificial arrangement ... operating structure is nothing but a ploy to clear the goods without the payment of the applicable duty," said the 95-page notice by the Office of the Commissioner of Customs in Maharashtra, which is not public but was seen by Reuters.

Since 2012, Volkswagen's India unit should have paid import taxes and several other related levies of about $2.35 billion to the Indian government, but paid only $981 million, amounting to a shortfall of $1.36 billion, the authority said.

In a statement, Skoda Auto Volkswagen India said it is a "responsible organization, fully complying with all global and local laws and regulations. We are analyzing the notice and extending our full cooperation to the authorities."

The notice asks to respond within 30 days, but Volkswagen didn't comment if it has done so or not. 

India's finance ministry and the customs department did not respond to Reuters queries.

The so-called "show cause notice" issued by the government authority asks Volkswagen's local unit to explain why its alleged tax evasion should not attract penalties and interests under Indian laws, over and above the $1.4 billion evaded duties.

A government official who spoke on condition of anonymity said the penalty typically in such cases, if the company is found guilty, could go as high as 100% of the amount evaded, which could force the company to pay up about $2.8 billion in total.

High taxes and prolonged legal disputes have often been a sore point for foreign companies in India. 

Electric vehicle maker Tesla, for example, has for years complained about high taxes on imported cars and Vodafone has fought cases related to back taxes. Chinese automaker BYD also faces an ongoing Indian tax investigation for underpaying taxes of roughly $9 million on imports.

BULK CAR ORDERS, USE OF SOFTWARE

Volkswagen is a tiny player overall in India's 4 million units a year car market and has struggled to boost sales. The case can increase its headaches in India, where its Audi brand already lags competitors in the luxury segment like Mercedes and BMW.

Indian investigators said in their notice that Mercedes was following the necessary rules to pay a 30% tax by importing the CKD units of their cars, and not separate the individual parts.

Inspectors searched three of Volkswagen India's facilities in 2022, including the two factories in Maharashtra. Documents related to component imports and email backup of top executives were seized at the time then.

The company's India Managing Director, Piyush Arora, was questioned last year and asked "why all the parts required to assemble a car are not shipped together", but "he was not able to answer this question," the investigators said in the notice. 

Arora did not respond to a Reuters request for comment.

MODUS OPERANDI    

The Indian notice, based on review of the company's internal software, said Volkswagen India regularly placed bulk orders for cars through an internal software which connected it to suppliers in Czech Republic, Mexico, Germany and other nations. 

After the order was placed, the software broke it down into "main components/parts", roughly 700-1,500 for each vehicle depending on the model. 

Then, the supplies started.

The car parts were packed abroad in different containers within a span of three to seven consecutive days under multiple invoices, and then reached the Indian port roughly at the same time, Indian authorities alleged.

"This appears to have been done to pay lesser duties applicable on these individual parts," the notice said.

Volkswagen told investigators it was using such a route for "efficiency of operations", but the argument was dismissed.

"Logistics is a very small and rather least significant step of the whole process ... is not a logistics company," the notice said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AstraZeneca, Daiichi Sankyo Submit New BLA for Datopotamab Deruxtecan for Accelerated Approval in US
AstraZeneca, Daiichi Sankyo Submit New BLA for Datopotamab Deruxtecan for Accelerated Approval in US
Nov 12, 2024
07:12 AM EST, 11/12/2024 (MT Newswires) -- AstraZeneca ( AZN ) and Daiichi Sankyo said Tuesday they have submitted a new Biologics License Application for accelerated approval in the US for datopotamab deruxtecan to treat adult patients with advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancer. The companies voluntarily withdrew the BLA for datopotamab deruxtecan for the...
AstraZeneca, Merck Trial of Koselugo Meets Primary Endpoint For Plexiform Neurofibromas
AstraZeneca, Merck Trial of Koselugo Meets Primary Endpoint For Plexiform Neurofibromas
Nov 12, 2024
07:19 AM EST, 11/12/2024 (MT Newswires) -- AstraZeneca ( AZN ) and Merck ( MRK ) said Tuesday their phase 3 study of Koselugo in adults with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas demonstrated a statistically significant and clinically meaningful objective response rate against placebo. Neurofibromatosis type 1 is a genetic condition in which about 30% to...
Mosaic misses quarterly profit estimates
Mosaic misses quarterly profit estimates
Nov 12, 2024
Nov 12 (Reuters) - Fertilizer producer Mosaic missed Wall Street estimates for third-quarter profit on Tuesday, hurt by production snags due to operational issues. The Tampa, Florida-based company reported adjusted earnings of 34 cents per share for the quarter ended Sept. 30, compared with analysts' average estimate of 54 cents per share according to data compiled by LSEG. ...
Bond hedge fund Arini up 23.4% betting against European satellites and autos, says letter
Bond hedge fund Arini up 23.4% betting against European satellites and autos, says letter
Nov 12, 2024
LONDON, Nov 12 (Reuters) - Former Credit Suisse bond trader Hamza Lemssouguer's main $3.7 billion fund at Arini jumped 23.4% through the end of October, benefiting from bets against European manufacturers facing U.S. and China headwinds, said a source and an investor letter. The year-to-date gains beat recent industry averages for hedge funds trading corporate debt, which have returned 9%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved